DHJJ Financial Advisors’s AstraZeneca AZN Stock Holding History

DHJJ Financial Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75.8K	Hold	400	–	–	0.02%	350
2026 Q1	$78.9K	Hold	400	–	–	0.03%	316
2025 Q4	$73.5K	Hold	400	–	–	0.02%	323
2025 Q3	$61.4K	Hold	400	–	–	0.02%	332
2025 Q2	$55.9K	Buy	+400	New	+$56.1K	0.02%	328

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DHJJ Financial Advisors's AZN Position: Q2 2026 in Review

DHJJ Financial Advisors held its AstraZeneca (AZN) position steady in Q2 2026 at 400 shares worth $75.8K. The position accounts for 0.02% of the portfolio, ranked #350.

DHJJ Financial Advisors first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. The position peaked at $78.9K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

DHJJ Financial Advisors held 400 shares of AstraZeneca worth $75.8K as of Q2 2026.
DHJJ Financial Advisors left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.02% of DHJJ Financial Advisors's portfolio in Q2 2026, its #350 holding.
DHJJ Financial Advisors first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
DHJJ Financial Advisors's AstraZeneca position peaked at $78.9K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on DHJJ Financial Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.